These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3931480)

  • 1. Lupus anticoagulant and pregnancy.
    Lubbe WF; Liggins GC
    Am J Obstet Gynecol; 1985 Oct; 153(3):322-7. PubMed ID: 3931480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obstetric complications associated with the lupus anticoagulant.
    Branch DW; Scott JR; Kochenour NK; Hershgold E
    N Engl J Med; 1985 Nov; 313(21):1322-6. PubMed ID: 3932854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupus anticoagulant in pregnancy.
    Lubbe WF; Butler WS; Palmer SJ; Liggins GC
    Br J Obstet Gynaecol; 1984 Apr; 91(4):357-63. PubMed ID: 6424702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal survival after prednisone suppression of maternal lupus-anticoagulant.
    Lubbe WF; Butler WS; Palmer SJ; Liggins GC
    Lancet; 1983 Jun; 1(8338):1361-3. PubMed ID: 6134138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of the lupus anticoagulant.
    Espinoza LR; Hartmann RC
    Am J Hematol; 1986 Jul; 22(3):331-7. PubMed ID: 3087160
    [No Abstract]   [Full Text] [Related]  

  • 6. Lupus anticoagulant, anti-Ro (SS-A) antibodies, and fetal wastage in systemic lupus erythematosus.
    Hubscher O; Eimon A; Arana RM; Riveros DA
    Arthritis Rheum; 1988 Feb; 31(2):302-3. PubMed ID: 3126746
    [No Abstract]   [Full Text] [Related]  

  • 7. [Circulating anticoagulants and pregnancy: a risky combination].
    Dantal J; Dantal F; Sagot P; Lopes P; Lerat MF
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(3):317-24. PubMed ID: 3135300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal loss treatment in patients with antiphospholipid antibodies.
    Ordi J; Barquinero J; Vilardell M; Jordana R; Tolosa C; Selva A; Genover E
    Ann Rheum Dis; 1989 Oct; 48(10):798-802. PubMed ID: 2510616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticardiolipin antibodies: their presence as a marker for lupus anticoagulant in pregnancy.
    Pattison NS; McKay EJ; Liggins GC; Lubbe WF
    N Z Med J; 1987 Feb; 100(817):61-4. PubMed ID: 3103033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies.
    Rosove MH; Tabsh K; Wasserstrum N; Howard P; Hahn BH; Kalunian KC
    Obstet Gynecol; 1990 Apr; 75(4):630-4. PubMed ID: 2107479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus.
    Lockshin MD; Druzin ML; Goei S; Qamar T; Magid MS; Jovanovic L; Ferenc M
    N Engl J Med; 1985 Jul; 313(3):152-6. PubMed ID: 3925336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population.
    Lockwood CJ; Romero R; Feinberg RF; Clyne LP; Coster B; Hobbins JC
    Am J Obstet Gynecol; 1989 Aug; 161(2):369-73. PubMed ID: 2504043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal demise associated with lupus anticoagulant: clinical features and results of treatment.
    Carp HJ; Frenkel Y; Many A; Menashe Y; Mashiach S; Nebel L; Toder V; Serr DM
    Gynecol Obstet Invest; 1989; 28(4):178-84. PubMed ID: 2620862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody to cardiolipin, lupus anticoagulant, and fetal death.
    Lockshin MD; Qamar T; Druzin ML; Goei S
    J Rheumatol; 1987 Apr; 14(2):259-62. PubMed ID: 3110418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.
    Derksen RH; Hasselaar P; Blokzijl L; Gmelig Meyling FH; De Groot PG
    Ann Rheum Dis; 1988 May; 47(5):364-71. PubMed ID: 3133992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Obstetric and thrombotic complications in women with lupus anticoagulant].
    Ordi Ros J; Vilardell Tarrés M; Barquinero Máñez J; Bosch Gil J; Rodrigo MJ; Monasterio Aspiri Y
    Med Clin (Barc); 1988 Jan; 90(1):11-3. PubMed ID: 3126370
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiphospholipid antibodies: an elderly statesman Dons new garments.
    Harris EN; Hughes GR; Gharavi AE
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():208-13. PubMed ID: 3112376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus anticoagulant. Implications for obstetric anaesthetists.
    Malinow AM; Rickford WJ; Mokriski BL; Saller DN; McGuinn WJ
    Anaesthesia; 1987 Dec; 42(12):1291-3. PubMed ID: 3124665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lupus-anticoagulant: clinical and obstetric implications.
    Lubbe WF; Butler WS; Liggins GC
    N Z Med J; 1984 Jun; 97(758):398-402. PubMed ID: 6087227
    [No Abstract]   [Full Text] [Related]  

  • 20. The striking association between lupus anticoagulant and fetal loss in systemic lupus erythematosus patients.
    Derksen RH; Bouma BN; Kater L
    Arthritis Rheum; 1986 May; 29(5):695-6. PubMed ID: 3087369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.